Trials that use: Fisher exact test
New to this method? Read the tutorial →
5,849 results
- Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REDEFINEIndependent statistical analysis of Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- REDIRECTIndependent statistical analysis of Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- REDPINEIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19): primary endpoint results, effect…
- Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: Complete Statistical AnalysisIndependent statistical analysis of Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: primary endpoint results, effect estimate with confidence…
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: primary endpoint results, effect…
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: Complete Statistical AnalysisIndependent statistical analysis of Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reducing Adolescent Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Reducing Adolescent Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04120376).
- Reducing Bacteria That Cause Tooth Decay: Complete Statistical AnalysisIndependent statistical analysis of Reducing Bacteria That Cause Tooth Decay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03062605).
- Reducing Preterm Births in Underserved Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Reducing Preterm Births in Underserved Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344616).
- Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: Complete Statistical AnalysisIndependent statistical analysis of Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REFLEXIONIndependent statistical analysis of Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00813709).
- ReFOCUS1Independent statistical analysis of Reducing Frailty for Older Cancer Survivors Using Supplements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04553666).
- Regadenoson Real Time Perfusion Imaging Trial-Optison: Complete Statistical AnalysisIndependent statistical analysis of Regadenoson Real Time Perfusion Imaging Trial-Optison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489176).
- REGALEIndependent statistical analysis of T-Reg Cell Kinetics, Stem Cell Transplant, REGALE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578539).
- REGARD-PGxIndependent statistical analysis of The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REGENT-1Independent statistical analysis of Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- REGKINEIndependent statistical analysis of T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00578461).
- Regulatory Request NIS in Korea: Complete Statistical AnalysisIndependent statistical analysis of Regulatory Request NIS in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642717).
- Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00288886).
- ReITIrateIndependent statistical analysis of Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies: primary endpoint results, effect estimate with confidence interval,…
- Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers – a Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01681589).
- Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Relative Bioavailability of Evobrutinib Tablet Batches: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Evobrutinib Tablet Batches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07214922).
- Relative Bioavailability of of Olodaterol and Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of of Olodaterol and Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01153711).
- Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study Between Two Formulations Containing Ambroxol Hydrochloride: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02572609).
- Relative Bioavailability Study of Emodepside IR-tablets and Solution: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Emodepside IR-tablets and Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03383523).
- Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- Relative Bioavailability Study of Ropinirole Implants in Parkinson’s Patients on L-Dopa Switched From Oral Ropinirole: Complete Statistical AnalysisIndependent statistical analysis of Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: Complete Statistical AnalysisIndependent statistical analysis of Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873987).
- Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: Complete Statistical AnalysisIndependent statistical analysis of Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RELAX-AHF-2Independent statistical analysis of Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RELAX-AHF-EUIndependent statistical analysis of Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test: Complete Statistical AnalysisIndependent statistical analysis of Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RELIEFIndependent statistical analysis of LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RELIEFIndependent statistical analysis of REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Relieving Acute Pain (RAP) Study: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Relieving Acute Pain (RAP) Study: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03426137).
- REMAINIndependent statistical analysis of A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After…
- Remicade Safety Line (Crohn’s Disease)(Study P03288)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00818272).
- remifentanilIndependent statistical analysis of Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693185).
- Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: Complete Statistical AnalysisIndependent statistical analysis of Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04265807).
- REMOTE-COVIDIndependent statistical analysis of Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337489).
- RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: Complete Statistical AnalysisIndependent statistical analysis of RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: Complete Statistical AnalysisIndependent statistical analysis of Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: Complete Statistical AnalysisIndependent statistical analysis of Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…